Galderma R&d
Clinical trials sponsored by Galderma R&d, explained in plain language.
-
New drug trial targets hardening skin in rare autoimmune disease
Disease control Not yet recruitingThis study is testing whether nemolizumab can reduce skin thickening and improve overall health in adults with systemic sclerosis, a rare autoimmune disease that causes skin and organ scarring. About 162 participants will receive either the drug or a placebo for 52 weeks to find …
Phase: PHASE2 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New Wrinkle-Fighting injections put to the test
Symptom relief Not yet recruitingThis study is testing the safety and effectiveness of two new injectable treatments, called GP0122 and GP0124, for smoothing lines and wrinkles in the cheek area. It will involve 60 adults who want to reduce moderate to severe cheek wrinkles. Researchers will track side effects, …
Phase: NA • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC